Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Guizhi Fuling Granules for Menopausal Syndrome
NCT06074809Phase 2Not yet recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Nov 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Modified Guizhi Fuling in menopause (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Greene Climacteric Scale (Chinese version) at Week 8. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
Modified Guizhi Fuling
03
Conditions
menopause
Beyond the preview
Go deeper on NCT06074809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06074809.